Management of patients with magnetically controlled growth rods amidst the global COVID-19 pandemic

European spine journal

article

Harry Hothi¹  Stewart Tucker²  Masood Shafafy³  Colin Nnadi⁴  Kenneth M. C. Cheung⁵  Elisabetta Dal Gal¹  Martina Tognini¹  Johann Henckel¹  John Skinner¹  Alister Hart¹ 

[1] The Royal National Orthopaedic Hospital and Institute of Orthopaedics and Musculoskeletal Science, University College London;Great Ormond Street Hospital for Children, NHS Foundation Trust;Department of Trauma and Orthopaedics, Nottingham University Hospitals NHS Trust;Nuffield Orthopaedic Centre, Oxford University Hospital;Department of Orthopaedics and Traumatology, The University of Hong Kong

关键词: COVID-19;    MAGEC rod;    MCGR;    EOS;   

DOI  :  10.1007/s00586-020-06516-2

来源: Springer

【 摘 要 】

At the time of writing, we are all coping with the global COVID-19 pandemic. Amongst other things, this has had a significant impact on postponing virtually all routine clinic visits and elective surgeries. Concurrently, the Magnetic Expansion Control (MAGEC) rod has been issued with a number of field safety notices and UK regulator medical device alerts. This document serves to provide an overview of the current situation regarding the use of MAGEC rods, primarily in the UK, and the impact that the pandemic has had on the management of patients with these rods. The care of each patient must of course be determined on an individual basis; however, the experience of the authors is that a short delay in scheduled distractions and clinic visits will not adversely impact patient treatment. The authors caution against a gap in distractions of longer than 6 months and emphasise the importance of continued remote patient monitoring to identify those who may need to be seen more urgently.

【 授权许可】

Unknown